Diseases

The Sabin Vaccine Institute works to extend the benefits of immunization to all people by enabling vaccine access and uptake. Sabin brings together national government officials, policy makers, immunization specialists, researchers and advocates to supply decision makers with the data and expertise they need to make evidence-based decisions on vaccines. Our work includes a number of diseases, including:

Supporting Evidence-Based Decisions

Vaccine introduction, policy and financing are complex issues, and countries must achieve ambitious immunization targets with limited available resources. To make informed decisions for the health of their people, decision makers need accurate, up-to-date information to identify vulnerable populations, assess burden of disease, evaluate vaccine efficacy and cost-effectiveness, and measure the efficiency of immunization programs.

The IAIM Joint Regional Meeting for the Americas and Europe was held from February 1-2, 2017 in Madrid, Spain. Presentations from the meeting are available online.

What do neglected tropical diseases (NTDs) have to do with women’s health? A recent review entitled, “Effective Health Interventions for Adolescents That Could Be Integrated with Human Papillomavirus Vaccination Programs”, has just been published looking at how combining multiple health interventions with human papillomavirus (HPV) vaccinations increases the effectiveness of HPV delivery.

New York Times reports on price cuts for HPV vaccine

Thanks to Pap tests, fatal cervical cancers are almost unknown today in rich countries. But the disease kills an estimated 275,000 women a year in poor countries where Pap tests are impractical and the vaccine is far too expensive for the average woman to afford, so the price cut could lead to a significant advance in women’s health.

Pages

Subscribe to RSS - Human Papillomavirus (HPV)